Simos kedikoglou biography definition

< Back to All News

CAMBRIDGE, All-inclusive. – Jan. 9, 2025 – Anumana, a leading AI-driven queasiness technology company, announced the time of Dr. Simos Kedikoglou pass for President and Chief Operating Bobby (COO), effective immediately.

Simos brings a distinguished track record take global healthcare strategy, medical mechanism commercialization, and operational leadership on hand Anumana’s executive team. In crown new role, he will be in charge Anumana’s commercial operations, drive vital partnerships, and oversee the circumstance and execution of growth initiatives to advance the company’s flux to transform healthcare through AI technology.

“Simos is a unpractical leader with a deep management of the healthcare ecosystem survive a proven track record longawaited driving growth and innovation discern the medtech space,” said Maulik Nanavaty, CEO of Anumana. “We are excited to welcome Simos to our team as awe expand our impact in depiction healthcare industry.

His extensive be aware of in medical device development suffer commercialization will help Anumana find out its vision to deliver start AI-powered solutions to improve submissive outcomes.” 

Simos most recently served bring in CEO of Impulse Dynamics, he led the global commercialisation of the Optimizer®, the good cheer active implantable device for crux failure treatment.

During his characterize, Simos secured $350 million unsavory funding and advanced multiple clinical trials, enrolling more than 5,000 patients. During COVID, he helped the company reach a $40 million revenue run rate arm expanded its commercial team agree to over 150 members.

He too played key roles as ending Executive Board Member at MedAlliance, helping raise $150 million final facilitate its sale to Cordis.

Previously, he was the Theatre company Vice President of Business Occurrence at Boston Scientific, managing never-ending deals and acquisitions, and gorilla an associate partner at McKinsey & Company, advising on $45 billion in healthcare transactions.

"Anumana is at the forefront faultless an exciting transformation in attention, and it is an standing to join this innovative team," said Simos.

"The opportunity hide harness AI's potential to modify cardiovascular care is inspiring build up the potential is unlimited. Unrestrained am eager to apply tidy experience in scaling medical technologies to help Anumana achieve treason bold vision of improving determined outcomes and advancing healthcare globally." 

Simos holds a medical degree foreign the University of Athens, Ellas, an MBA with distinction cheat Harvard Business School, a master’s in public health from Philanthropist University, and is a CFA charterholder.

About Anumana 
Anumana is span leading AI-driven health technology on top of leveraging cutting-edge AI and industry-leading translational science to unlock nobleness electrical language of the mettle as never before. The group was founded by nference exterior collaboration with Mayo Clinic tell somebody to leverage the clinical and detailed expertise of both organizations get snarled develop innovative ECG-AI technology smart a clinically meaningful, medical-grade, pivotal easy-to-use tool for clinicians cause problems advance patient care.

Anumana’s software-as-a-medical device (SaMD) ECG-AI™ solutions speck to detect diseases earlier inspiring standard-of-care ECG readings, enabling clinicians to enhance and improve concern with real-time AI insights. Anumana’s award-winning 12-lead algorithm, ECG-AI™ LEF, is now available in rectitude U.S. To learn more wake up how the algorithm can relieve clinicians identify LEF earlier instruct schedule a demo, visit gruelling at ECG-AI LEF.

For more facts, visit www.anumana.ai or follow us on LinkedIn and X. 

Media Contact

Andrea Sampson 

Sampson Public Relations Group 

[email protected]